Drug Database
Back to search

Ireland· IE-PA-PA0281/231/001

Hyaluronidase 1500 I.U. Powder for Solution for Injection or Infusion

A hyaluronidase product containing hyaluronidase, registered in Ireland by Pinewood Laboratories Ltd. The same ATC class is registered in 7 of our 19 countries.

ATC B06AA03

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedHyaluronidase 1500 I.U. Powder for So…ATCB06AA03REGISTER NO.IE-PA-PA0281/231/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hyaluronidaseAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hyaluronidase is registered in 7 of 19 countries.

Countries holding a registration under ATC B06AA03 (hyaluronidase), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 3 of them publish a price we can compare per daily dose
Search hyaluronidase products by name

Hyaluronidase · ATC B06AA03

7 / 19 countries

  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Hyaluronidase
Manufacturer
Pinewood Laboratories Ltd
Country
Ireland (IE)
ATC code
B06AA03
ATC class
Hyaluronidase
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0281/231/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

84 interactions on record for hyaluronidase.

Graded by severity as the source publishes them — 84 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hyaluronidase against other medicinesHow interaction checks work

Hyaluronidase · interactions on record

84 records

  • 84 minor

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Hyaluronidase in 5 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All hyaluronidase products

    Authorised across Europe · EMA

    The same active substance is authorised in 5 EEA countries. Names it is sold under:

    • Austria · Hylase Dessau
    • Germany · Hylase Dessau
    • United Kingdom (Northern Ireland) · Hyalase, Hyaluronidase Wockhardt Uk
    • Malta · Hyalase
    • Netherlands · Hyason

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/9b45654d-455a-41e7-b9e6-533c50c2b06d
GET /v1/drugs/9b45654d-455a-41e7-b9e6-533c50c2b06d?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Powder for solution for injection/infusion",
  "routes": [
    "Intramuscular use",
    "Not Currently Available",
    "Subcutaneous use"
  ],
  "source": "hpra",
  "atc_all": [
    "B06AA",
    "B06AA03"
  ],
  "strength": null,
  "pa_number": "PA0281/231/001",
  "substances": [
    "Hyaluronidase"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "22/03/1984",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
    API referenceMCP serverPlans

    See everything about hyaluronidase.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console